...
首页> 外文期刊>Journal of biomedical materials research, Part A >Indomethacin-loaded methoxy poly(ethylene glycol)/poly(D,L-lactide) amphiphilic diblock copolymeric nanospheres: pharmacokinetic and toxicity studies in rodents.
【24h】

Indomethacin-loaded methoxy poly(ethylene glycol)/poly(D,L-lactide) amphiphilic diblock copolymeric nanospheres: pharmacokinetic and toxicity studies in rodents.

机译:吲哚美辛负载的甲氧基聚(乙二醇)/聚(D,L-丙交酯)两亲性二嵌段共聚物纳米球:在啮齿动物中的药代动力学和毒性研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Biodegradable methoxy poly(ethylene glycol)/poly(D,L-lactide) amphiphilic block copolymeric nanospheres were prepared for application as a particulate drug carrier. Drug-loaded nanospheres (ML50) showed a narrow size distribution with the average diameter of <200 nm. When the feed weight ratio of indomethacin (IMC) to polymer was 1:1, the ML50 nanosphere having a relatively high drug-loading efficiency of about 33.0% could be obtained. To investigate pharmacokinetic characteristics of IMC in rats, the IMC concentration in plasma was analyzed using a high-performance liquid chromatography system after intravenous bolus injection of free IMC and IMC-loaded ML50 nanospheres. ML50 nanosphere system exhibited a significant potential for sustained release of drug and showed slow clearance of IMC, but there was no significant effect on metabolism of IMC in the rats. Median lethal dose (LD50) and major organs (e.g., heart, lung, liver, and kidney) toxicities were determined using ICR mice to estimate the acutetoxicity of ML50 nanospheres. The LD50 of ML50 nanospheres determined by Litchfield-Wilcoxon method was about 1.54 g/kg. After the mice were intraperitoneally administered with a half dose of LD50 for 7 days, no significant histopathologic changes were observed in ML50-treated mice compared with normal mice in the light and electron microscopic observations of major organs. This indicates that ML50 nanospheres might be a useful candidate as a novel sustained drug carrier for hydrophobic drugs.
机译:制备了可生物降解的甲氧基聚(乙二醇)/聚(D,L-丙交酯)两亲嵌段共聚物纳米球,以用作颗粒状药物载体。载药纳米球(ML50)的粒径分布较窄,平均直径小于200 nm。当吲哚美辛(IMC)与聚合物的进料重量比为1:1时,可获得具有约33.0%的相对较高的药物装载效率的​​ML50纳米球。为了研究IMC在大鼠中的药代动力学特性,在静脉推注游离IMC和载有IMC的ML50纳米球后,使用高效液相色谱系统分析了血浆中IMC的浓度。 ML50纳米球系统具有持续释放药物的显着潜力,并显示IMC清除缓慢,但对大鼠IMC的代谢没有明显影响。使用ICR小鼠确定ML50纳米球的急性毒性,确定中位致死剂量(LD50)和主要器官(例如,心脏,肺,肝和肾)的毒性。通过Litchfield-Wilcoxon方法测定的ML50纳米球的LD50为约1.54g / kg。在小鼠腹膜内给予半剂量的LD50 7天后,在主要器官的光镜和电镜观察中,与正常小鼠相比,在ML50处理的小鼠中未观察到明显的组织病理学变化。这表明ML50纳米球可能作为疏水药物的新型持续药物载体有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号